Genetic mutations, most notably in the ARID1A gene, are involved in the pathogenesis of EAOC (endometriosis-associated ovarian cancer); these disrupt chromatin remodeling and activate oncogenic pathways such as PI3K/Akt [2]. This evidence concerns the gene ARID1A and endometriosis.